Mark A. Kronenfeld - Net Worth and Insider Trading
Mark A. Kronenfeld Net Worth
The estimated net worth of Mark A. Kronenfeld is at least $471,228 dollars as of 2024-04-27. Mark A. Kronenfeld is the Director of Pacira BioSciences Inc and owns about 17,897 shares of Pacira BioSciences Inc (PCRX) stock worth over $471,228. Details can be seen in Mark A. Kronenfeld's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark A. Kronenfeld has not made any transactions after 2023-06-08 and currently still holds the listed stock(s).
Transaction Summary of Mark A. Kronenfeld
Mark A. Kronenfeld Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A. Kronenfeld owns 1 companies in total, including Pacira BioSciences Inc (PCRX) .
Click here to see the complete history of Mark A. Kronenfeld’s form 4 insider trades.
Insider Ownership Summary of Mark A. Kronenfeld
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2023-06-08 | director |
Mark A. Kronenfeld Latest Holdings Summary
Mark A. Kronenfeld currently owns a total of 1 stock. Mark A. Kronenfeld owns 17,897 shares of Pacira BioSciences Inc (PCRX) as of June 8, 2023, with a value of $471,228.
Latest Holdings of Mark A. Kronenfeld
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2023-06-08 | 17,897 | 26.33 | 471,228 |
Holding Weightings of Mark A. Kronenfeld
Mark A. Kronenfeld Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark A. Kronenfeld has made a total of 1 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 15,000 shares on June 8, 2023, which brought Mark A. Kronenfeld around $555,600.
Insider Trading History of Mark A. Kronenfeld
- 1
Mark A. Kronenfeld Trading Performance
GuruFocus tracks the stock performance after each of Mark A. Kronenfeld's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark A. Kronenfeld is 11.84%. GuruFocus also compares Mark A. Kronenfeld's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark A. Kronenfeld within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark A. Kronenfeld's insider trading performs compared to the benchmark.
Performance of Mark A. Kronenfeld
Average Return
28.72%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.78 | 11.84 | 8.54 | 28.72 | 8.47 | 4.23 |
| Relative Return to S&P 500(%) | 11.53 | 10.68 | 3.73 | 21.24 | -0.88 | -7.71 |
Mark A. Kronenfeld Ownership Network
Ownership Network List of Mark A. Kronenfeld
Ownership Network Relation of Mark A. Kronenfeld
Mark A. Kronenfeld Owned Company Details
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Mark A. Kronenfeld is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Clinical Officer Roy Winston , Executive Director & Accounting Lauren Bullaro Riker , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Mark A. Kronenfeld made 1 insider transaction in Pacira BioSciences Inc (PCRX) with a net sale of 15,000. Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 8,216 shares made by Lauren Bullaro Riker , a net sale of 124,338 shares made by Gary W Pace , and a net sale of 9,125 shares made by Kristen Marie Williams .
In summary, during the past 3 months, insiders sold 119,323 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 119,323 shares. During the past 18 months, 209,500 shares of Pacira BioSciences Inc (PCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209,500 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
Mark A. Kronenfeld Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A. Kronenfeld. You might contact Mark A. Kronenfeld via mailing address: C/o Pacira Pharmaceuticals, Inc., 5 Sylvan Way, Suite 100, Parsippany Nj 07054.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
